Literature DB >> 16625421

Differential involvement of mitochondrial permeability transition in cytotoxicity of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine.

Chung Soo Lee1, Woo Jae Park, Hyun Hee Ko, Eun Sook Han.   

Abstract

Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the influence of the mitochondrial membrane permeability transition inhibition against the toxicity of 1-methyl-4-phenylpyridinium (MPP(+)) and 6-hydroxydopamine (6-OHDA) in relation to the mitochondria-mediated cell death process and role of oxidative stress. Both MPP(+) and 6-OHDA induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in differentiated PC12 cells. Cyclosporin A (CsA), trifluoperazine and aristolochic acid, inhibitors of mitochondrial permeability transition, significantly attenuated the MPP(+)-induced mitochondrial damage leading to caspase-3 activation, increased oxidative stress and cell death. In contrast to MPP(+), the cytotoxicity of 6-OHDA was not reduced by the addition of the mitochondrial permeability transition inhibitors. The results show that the cytotoxicity of MPP(+) may be mediated by the mitochondrial permeability transition formation, which is associated with formation of reactive oxygen species and the depletion of GSH. In contrast, the 6-OHDA-induced cell injury appears to be mediated by increased oxidative stress without intervention of the mitochondrial membrane permeability transition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625421     DOI: 10.1007/s11010-006-9164-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

Review 1.  Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases.

Authors:  Ronald Jemmerson; Janet M Dubinsky; Nickolay Brustovetsky
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

2.  Combined effect of dopamine and MPP+ on membrane permeability in mitochondria and cell viability in PC12 cells.

Authors:  Chung Soo Lee; Eun Hyang Song; Se Young Park; Eun Sook Han
Journal:  Neurochem Int       Date:  2003-07       Impact factor: 3.921

3.  Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.

Authors:  D H Kim; Y Y Jang; E S Han; C S Lee
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

4.  Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes.

Authors:  R J van Klaveren; P H Hoet; J L Pype; M Demedts; B Nemery
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

5.  Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.

Authors:  Nicole A Abramova; David S Cassarino; Shaharyar M Khan; Terry W Painter; James P Bennett
Journal:  J Neurosci Res       Date:  2002-02-15       Impact factor: 4.164

6.  Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation.

Authors:  María F Galindo; Joaquín Jordán; Carmen González-García; Valentín Ceña
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

7.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

Authors:  D S Cassarino; J K Parks; W D Parker; J P Bennett
Journal:  Biochim Biophys Acta       Date:  1999-01-06

8.  Inhibition of the functional expression of N-methyl-D-aspartate receptors in a stably transformed cell line by cyclosporin A.

Authors:  Ralf Dirk Steinmetz; Beate Firla; Dieter Steinhilber
Journal:  Biochem Pharmacol       Date:  2004-08-01       Impact factor: 5.858

9.  Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells.

Authors:  Joaquín Jordán; María F Galindo; Daniel Tornero; Carmen González-García; Valentín Ceña
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

10.  Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation. Rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC.

Authors:  Julia A Yaglom; Daryoush Ekhterae; Vladimir L Gabai; Michael Y Sherman
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  7 in total

1.  Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.

Authors:  Anna Sandebring; Nodi Dehvari; Monica Perez-Manso; Kelly Jean Thomas; Elena Karpilovski; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  FEBS J       Date:  2009-08-03       Impact factor: 5.542

2.  An active fraction of Achyranthes bidentata polypeptides prevents apoptosis induced by serum deprivation in SH-SY5Y cells through activation of PI3K/Akt/Gsk3β pathways.

Authors:  Yuntian Shen; Qi Zhang; Xiaorong Gao; Fei Ding
Journal:  Neurochem Res       Date:  2011-07-07       Impact factor: 3.996

3.  Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.

Authors:  Sonal Agrawal; Anubhuti Dixit; Ashish Singh; Pratibha Tripathi; Dhirendra Singh; Devendra Kumar Patel; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

4.  Lactacystin requires reactive oxygen species and Bax redistribution to induce mitochondria-mediated cell death.

Authors:  Sergio Perez-Alvarez; Maria E Solesio; Jorge Manzanares; Joaquín Jordán; María F Galindo
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

5.  Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  Lichuan Yang; Kesheng Zhao; Noel Y Calingasan; Guoxiong Luo; Hazel H Szeto; M Flint Beal
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

6.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

Review 7.  How Parkinsonian toxins dysregulate the autophagy machinery.

Authors:  Ruben K Dagda; Tania Das Banerjee; Elzbieta Janda
Journal:  Int J Mol Sci       Date:  2013-11-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.